CARESIDE Submits Direct Bilirubin Test for FDA Clearance
16 nov. 1999 09h00 HE
|
Careside, Inc
Test Aiding in Diagnosis and Treatment of Liver Diseases including Hepatitis Will Make CARESIDE Analyzer(tm); First Diagnostic Device Providing Rapid Direct Bilirubin Result
CULVER CITY, Calif.,...
CARESIDE Reports Third Quarter Results
04 nov. 1999 08h30 HE
|
Careside, Inc
Company Rapidly Approaches December Launch of Blood-Testing
System; Sales, Operational and Production Infrastructure
is In Place; Test Menu has Expanded with
Additional FDA Test Approvals
CULVER...
CARESIDE On Schedule with FDA Point-of-Care Marketing Submission
02 nov. 1999 15h21 HE
|
Careside, Inc
CULVER CITY, Calif. November 2, 1999 (PRIMEZONE) -- CARESIDE, Inc. (AMEX:CSA) (AMEX:CSA.W) announced its filing of a premarket notification to the U.S. Food and Drug Administration (FDA) to add the...
Careside Submits CO2 Test for FDA Clearance
11 août 1999 08h30 HE
|
Careside, Inc
CULVER CITY, Calif., Aug. 11, 1999 (PRIMEZONE) -- CARESIDE, Inc. (AMEX:CSA) announced submission of its CARESIDE(TM) CO2 blood test to the U.S. Food and Drug Administration (FDA). The test is...
Careside Receives FDA Clearance for Its Coagulation Blood Test
09 août 1999 08h53 HE
|
Careside, Inc
CULVER CITY, Calif, August 9, 1999, (PRIMEZONE) -- CARESIDE, Inc. (AMEX:CSA) today announced clearance of its coagulation test CARESIDE(TM) PT by the U.S. Food and Drug Administration (FDA), bringing...